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Abstract 
Thirteen mono-N-acyl derivatives of 2,6-diaminopimelic acid (DAP)—new potential inhibitors of the dapE-
encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18)—were analyzed and characterized 
by infrared (IR) and nuclear magnetic resonance (NMR) spectroscopies and two capillary electromigration 
methods: capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). Structural 
features of DAP derivatives were characterized by IR and NMR spectroscopies, whereas CZE and MEKC were 
applied to evaluate their purity and to investigate their electromigration properties. Effective electrophoretic 
mobilities of these compounds were determined by CZE in acidic and alkaline background electrolytes (BGEs) 
and by MEKC in acidic and alkaline BGEs containing a pseudostationary phase of anionic detergent sodium 
dodecyl sulfate (SDS) or cationic detergent cetyltrimethylammonium bromide (CTAB). The best separation of 
DAP derivatives, including diastereomers of some of them, was achieved by MEKC in an acidic BGE 
(500 mM acetic acid [pH 2.54] and 60 mM SDS). All DAP derivatives were examined for their ability to 
inhibit catalytic activity of DapE from Haemophilus influenzae (HiDapE) and ArgE from Escherichia coli (EcArgE). 
None of these DAP derivatives worked as an effective inhibitor of HiDapE, but one derivative—N-fumaryl, Me-
ester-DAP—was found to be a moderate inhibitor of EcArgE, thereby providing a promising lead structure for 
further studies on ArgE inhibitors. 
Keywords 
2,6-Diaminopimelic acid derivatives, Capillary zone electrophoresis, Micellar electrokinetic chromatography, 
Enzyme inhibition, IR spectroscopy, NMR spectroscopy 
 
The World Health Organization reported that bacterial infections represent a significant and permanently 
growing medical problem around the world due to the increasing number of disease-causing microbes that have 
become resistant to currently available antibiotics [1], [2], [3]. In fact, several pathogenic bacteria, some of 
which were thought to have been eradicated, have made a significant resurgence due to 
bacterial resistance to antibiotics [4], [5]. For example, resistance to tetracyclinesincreased from 0% in 1948 to 
98% in 1998 [4], [5], and tuberculosis is currently one of the leading causes of death in adults by an infectious 
disease worldwide, which is significant given that death ratesdue to tuberculosis had declined to near 
imperceptible levels in industrial nations [6], [7]. According to the Centers for Disease Control and Prevention 
(USA), several bacterial strains currently exhibit multidrug resistance, with more than 60% of hospital-acquired 
infections in the United States alone caused by the so-called ESKAPE pathogens (Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter sp.). These findings have stimulated an intensive search for new potent 
antimicrobial agents that are active against drug-resistant bacterial strains [5], [8]. 
 
Inhibitors of cell wall biosynthesis—vancomycin and β-lactams, to name a couple—have proven to be very 
potent antibiotics, evidence that interfering with cell wall synthesis has deleterious effects on bacterial cell 
survival. Enzymes that are targeted by these antibiotics tend to be present in all bacteriaand are highly similar in 
structure and function. Unfortunately, only two new antibacterial drugs have emerged since 1962. Because 
every antibiotic has a finite lifetime given that resistance will ultimately occur, particularly if the same enzymes 
are repeatedly targeted, development of new classes of inhibitors that target previously untargeted cellular 
enzymes is essential to retain control of infectious disease [5], [8]. As such, antimicrobial peptides have been 
introduced as an innate defense system and shown to provide protection against a wide variety 
of microorganisms [9], [10], [11], [12]. Another approach targets microbial enzymes, especially those 
catalyzing metabolic processes exclusive to bacteria, as potential targets for potent and selective antibiotics [8]. 
 
Recently, we described a series of inhibitors for the bacterial enzyme Nα-acetyl-l-ornithine deacetylase 
(ArgE),2 which catalyzes the conversion of Nα-acetyl-l-ornithine to l-ornithine in the fifth step of the biosynthetic 
pathway for arginine, a necessary step for bacterial growth [13]. Based on bacterial geneticinformation, 
the meso-diaminopimelate (mDAP)/lysine biosynthetic pathway (Fig. 1) offers several potential antibacterial 
targets that have yet to be explored [14], [15], [16], [17]. One of the products of this pathway, lysine (10), is 
required in protein synthesis and is also used in the peptidoglycan layer of gram-positive bacteria cell walls. A 
second product, meso-diaminopimelic acid (mDAP) (9), is an essential component of the peptidoglycan cell wall 
in gram-negative bacteria, providing a link between polysaccharide strands. It has been shown that deletion of 
the gene encoding for one of the enzymes in the mDAP/lysine biosynthetic pathway, the DapE-encoded N-
succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18) [18], is lethal to Helicobacter 
pylori and Mycobacterium smegmatis [19], [20]. Even in the presence of lysine-supplemented media, H. 
pylori was unable to grow. Therefore, DapE is essential for cell growth and proliferation and is a part of a 
biosynthetic pathway that is the only source of lysine in bacteria. Because there are no similar biosynthetic 
pathways in mammals, inhibitors that target one or more of the enzymes in the mDAP/lysine biosynthetic 
pathway are hypothesized to exhibit selective toxicity only against bacteria, providing a previously nondescribed 
class of antimicrobial agents [14], [21]. 
 
Fig.1. Biosynthetic reactions leading from aspartate to lysine: l-aspartate (1); N-succinyl-l,l-diaminopimelate 
(7); l,l-diaminopimelate (8); d,l-diaminopimelate (9); l-lysine (10). 
 
With the aim of developing new antimicrobial agents that target DapE enzymes, a methodology for the quick 
and efficient preparation of mono-N-acylated 2,6-diaminopimelic acid (DAP) derivatives was recently 
reported [22]. These compounds were designed as competitive inhibitors of the mono-N-succinyl–
DAP hydrolysis reaction catalyzed by DapE, in which the structure of the N-linked succinatemoiety was altered to 
inhibit the enzyme’s ability to cleave the adjacent amide bond. The syntheses of a series of 13 DAP derivatives 
(Table 1) bearing different N-linked acyl side chains comprising (i) a hydrophobic aliphatic or aromatic moiety 
(A1–A6), (ii) an aliphatic moiety terminated by a carboxyl group (C1–C4), (iii) an aliphatic moiety terminated by 
an ester group (E1–E3), and their purificationand characterization by high-performance liquid 
chromatography (HPLC), elemental analysis, and electrospray ionization–mass spectrometry (ESI–MS) were 
described previously [22]. 
 
Table 1. Name, indication, structural formula, and relative molecular mass (Mr) of 2,6-diaminopimelic acid and 
its mono-N-acyl derivatives. 
Compound name and indication Structural formula Mr 
2,6-Diaminopimelic acid 
 
190.2 
DAP 
  
N-Acetyl-DAP 
 
232.1 
A1 
  
N-Isobutyryl-DAP 
 
260.3 
A2 
  
N-Butyryl-DAP 
 
260.3 
A3 
  
N-Pivalyl DAP 
 
274.3 
A4 
  
N-Valeryl-DAP 
 
274.3 
A5 
  
N-Benzoyl-DAP 
 
294.2 
A6 
  
N-Glutaryl-DAP 
 
304.3 
C1 
  
N-3-Me-glutaryl-DAP 
 
318.3 
C2 
  
N-3,3-di-Me-glutaryl-DAP 
 
332.4 
C3 
  
N-2,3-Tetrafluoro-succinyl-DAP 
 
362.2 
C4 
  
N-Fumaryl, Me-ester-DAP 
 
302.3 
E1 
  
N-Malonyl, Et-ester-DAP 
 
304.3 
E2 
  
N-2-Me-succinyl, Me-ester-DAP 
 
318.3 
E3 
  
 
We report here the analytical characterization of these DAP derivatives in order to confirm their structural 
properties using infrared (IR) and 1H and 13C nuclear magnetic resonance (NMR) spectroscopies. We also 
performed qualitative and quantitative analysis of each of these compounds by two capillary electromigration 
methods: capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). These two 
techniques are excellent tools for separation of both ionogenic and electroneutral 
compounds [23], [24], [25] and are frequently used for analysis and characterization of amino acids and their 
derivatives [26], [27], [28]. In addition, these DAP derivatives were characterized by their 
effective electrophoretic mobilities determined by CZE in acidic and alkaline classical or isoelectric background 
electrolytes (BGEs) or by MEKC in acidic and alkaline BGEs containing a micellar pseudostationary phase 
constituted by the anionic detergent sodium dodecyl sulfate (SDS) or the cationic 
detergent cetyltrimethylammonium bromide (CTAB). Finally, all of these DAP derivatives were tested for 
their inhibition activity toward both DapE and ArgE. 
Materials and methods 
Chemicals 
All chemicals used were of analytical reagent grade. Tris(hydroxymethyl)aminomethane (Tris) was purchased 
from Serva (Heidelberg, Germany). Phosphoric acid (H3PO4), acetic acid (AcOH), and sodium hydroxide (NaOH) 
were obtained from Lachema (Brno, Czech Republic). Iminodiacetic acid(IDA) was obtained from Bachem 
(Bubendorf, Switzerland). SDS and CTAB were supplied by Fluka (Buchs, Switzerland). Acetonitrile (ACN) was 
obtained from Sigma–Aldrich (Prague, Czech Republic) and methanol (MeOH) from Penta (Chrudim, Czech 
Republic). 
IR and NMR spectroscopies 
Fourier transform (FT)-IR spectra (KBr, νmax cm–1) were recorded on a Nicolet 6700 FT-IR instrument (Madison, 
WI, USA). 1H and 13C NMR spectra were obtained on a Bruker AVANCE-600 NMR spectrometer (Bruker BioSpin, 
Rheinstetten, Germany) using a 5-mm CPTCI cryoprobe (1H at 600.13 MHz, 13C at 150.9 MHz) in dimethyl 
sulfoxide (DMSO)-d6 at 300 K. A series of proton 1D (one-dimensional), 2D–COSY (two-dimensional correlation 
spectroscopy), 2D–TOCSY (total correlation spectroscopy) (spin-lock time 90 ms), and 2D–ROESY (rotating frame 
NOE [nuclear Overhauser effect] spectroscopy) (mixing time 300 ms) spectra were recorded at 27 °C for 
complete structural assignment of the observed proton signals. The structural assignment of the 13C signals was 
achieved by combining 1D–APT (attached proton test), 2D–H,C–HSQC (heteronuclear single quantum 
coherence), and 2D–H,C–HMBC (heteronuclear multiple bond coherence) spectra. 
Capillary electromigration methods 
CZE and MEKC were performed on a homemade manually operated apparatus for high-performance capillary 
electrophoresis [29] equipped with an ultraviolet (UV) absorption photometric detector operating at 206 nm. 
Internally untreated fused silica capillary with outer polyimide coating (Polymicro Technologies, Phoenix, AZ, 
USA) with inner diameter of 50 μm, outer diameter of 375 μm, total length of 400 mm, and effective length 
(from injection to detector) of 290 mm was used for all separations. Data acquisition and evaluation was carried 
out by Chromatography and ElectrophoresisStation Clarity (DataApex, Prague, Czech Republic). The analyzed 
DAP derivatives were dissolved in the BGE or water in the concentration range 0.5 to 1.1 mg/ml and were 
analyzed as cations in acidic BGEs or as anions in alkaline BGEs. The BGEs were passed through a 0.45-μm 
Millipore filter (Bedford, MA, USA). The nanoliter sample volumes were introduced into the capillary 
hydrodynamically by pneumatically induced pressure (600–1000 Pa) for a period of 3 to 20 s. The applied 
separation voltagewas +12 kV or –12 kV (anode or cathode at the injection capillary end), whereas the electric 
current was in the range 7.1 to 45.0 μA at an ambient temperature of 22 to 26 °C. 
Determination of IC50 
The DapE from Haemophilus influenzae (HiDapE) was purified as described previously [18]. IC50 values were 
determined using 3 mM N-succinyl-2,6-diaminopimelic acid (mixture of d,d–l,l isoforms, 1:1) as the substrate. 
All kinetic experiments were performed in 50 mM Chelex-100-treated sodium phosphatebuffer at pH 7.5 and 
25 °C. Catalytic activities were determined by monitoring the initial rates of amidebond cleavage at 225 nm 
(ε = 698 M–1 cm–1) in 50 mM phosphate buffer (pH 7.0) on a Shimadzu UV-2600 UV–Vis (ultraviolet–visible) 
spectrometer at 25 °C in the presence of two equivalents of Zn(II). Measurements were performed in triplicate 
at a minimum of five inhibitor concentrations. Enzyme activities were expressed as units per milligram, where 
1 unit is defined as the amount of enzyme that cleaves 1 μmol of dd,ll-N-succinyl-2,6-diaminopimelic acid at 
25 °C in 1 min. These data provide a dose–response curve that allows for the concentration required for 
50% inhibition (IC50) of DapE to be extracted. 
 
The ArgE from Escherichia coli (EcArgE) was purified as described previously [30]. IC50 values were determined 
spectrophotometrically using 2 mM Nα-acetyl-l-ornithine (L-NAO) as the substrate. The rate of L-
NAO deacetylation was monitored as a decrease in absorbance at 214 nm using a Shimadzu UV-2600 UV–Vis 
spectrophotometer at 25 °C. All kinetic experiments were performed in 50 mM Chelex-100-treated sodium 
phosphate buffer at pH 7.5 and 25 °C. Initial rates of L-NAO deacetylationwere determined in triplicate at a 
minimum of five inhibitor concentrations, providing a dose–response curve from which the concentration 
required for 50% inhibition (IC50) of ArgE could be extracted. Catalytic activities were determined with 
an error of ±10%. 
Results and discussion 
IR and NMR spectroscopies 
The structural features of the DAP derivatives were characterized by IR and NMR spectroscopies. IR 
(KBr, νmax cm–1) spectra of each of the DAP derivatives reveal characteristic bands corresponding to the 
functional groups present in these compounds (see Table SI-1 in the online supplementary material)—that is, 
broad bands in the range ν(3427–3050 cm–1) due to amino groups and/or carboxylic OH groups, relatively sharp 
bands in the ν(1735–1726 cm–1) range due to carboxylic C O groups, and bands in the ν(1670–1630 cm–1) 
and ν(1550–1522 cm–1) ranges due to amide I and amide II groups, respectively. The IR spectra also show distinct 
C O and/or C F bands at ν ∼ 1200 cm–1 due to trifluoroacetatecounterions, which originate from the 
HPLC purification of DAP derivatives where 0.05% (v/v) trifluoroacetic acid was used as an acid modifier of 
the mobile phase. 
 
The 1H and 13C chemical shift data for each DAP derivative were assigned according to the following general 
formula: 
 
where R indicates the various acyl substituents (see Tables SI-2 and SI-3 in supplementary material). Signals due 
to minor isomers (if resolved from a major isomer) are in italics. The series of DAP derivatives examined were 
prepared from an enantiomeric/diastereomeric mixture of RS,RS-2,6-diaminopimelic acid, and the mixtures of 
two diastereoisomeric forms were also detected. Due to the additional chiral center on the acyl substituent R in 
compounds C2 and E3, ratios of four isomerswithout any ascribed priority were estimated. 
Capillary electromigration methods 
Selection of experimental conditions 
The DAP derivatives examined (Table 1) are typical amphoteric compounds containing both acidic (carboxylic) 
and basic (amino) groups with different acyl substituents R on one of the two amino groups. Hence, the 
experimental conditions for CZE and MEKC analyses and separations of DAP derivatives were selected based on 
the general rules for suitable capillary electrophoresis separation conditions for amino acids 
and oligopeptides [31], [32], [33], [34], [35] while also taking into account the specific properties of the DAP 
derivatives. The selection of BGEs includes the type and concentration of buffer components and pH, and it also 
takes into account the solubility and chemical stability of each compound. Effective mobility of weak electrolytes 
and ampholytes strongly depends on pH; therefore, pH is one of the most important parameters influencing 
separation efficiency and selectivity of the BGEs. 
 
For CZE analysis and separation of amphoteric DAP derivatives, either acidic or alkaline BGEs are suitable. 
Therefore, the following BGEs were used: (i) acidic BGEs (pH 2.18–2.54) in which the amino groups are fully 
protonated and the carboxylic groups are only partially dissociated, resulting in cationic migration of the DAP 
derivatives; and (ii) basic BGEs (pH 8.20–8.64) in which the amino groups are partially protonated and the 
carboxylic groups are fully dissociated, resulting in anionic migration of the DAP derivatives. BGE compositions 
were also selected with respect to their buffering capacity in order to maintain proper pH in the zone of 
migrating analytes (i.e., pH of the BGE was close to the pKa value of the buffering constituent of the BGE). With 
the addition of anionic (SDS) or cationic (CTAB) detergents, the same BGEs were also employed for the 
separation of DAP derivatives by MEKC. The complete composition and pH of the BGEs used, as well as the 
separation voltages and electric currents employed in the CZE and MEKC analyses and separations of DAP 
derivatives, are presented in Table 2. 
 
Table 2. Background electrolytes, separation voltage (Usep), and electric current (I) used in CZE and MEKC 
methods. 
BGE number BGE composition pH Method Usep (kV) I (μA) 
BGE I 500 mM AcOH 2.54 CZE 12.0 7.1 
BGE II 100 mM Tris, 50 mM AcOH 8.20 CZE 12.0 23.3 
BGE III 20 mM Tris, 5 mM H3PO4, 50 mM SDS 8.64 MEKC 12.0 18.6 
BGE IV 200 mM iminodiacetic acid 2.28 CZE 12.0 35.0 
BGE V 50 mM Tris, 100 mM H3PO4 2.18 CZE 12.0 45.0 
BGE VI 500 mM AcOH, 60 mM SDS 2.54 MEKC –12.0 24.0 
BGE VII 100 mM Tris, 50 mM AcOH, 5 mM CTAB 8.20 MEKC –12.0 23.0 
BGE VIII 100 mM Tris, 50 mM AcOH, 10 mM CTAB 8.20 MEKC –12.0 23.5 
 
Determination of purity of DAP derivatives 
DAP derivatives were synthesized for the first time; their standard preparations were not available, and for that 
reason their purity degree could be quantified only relatively by the relative corrected peak area, PCA [36], 
defined by the following relation: 
 
(1) 𝑃𝑃CA(𝑖𝑖)(%) = 𝐴𝐴c,(𝑖𝑖)∑𝑛𝑛𝑖𝑖=1 𝐴𝐴c,(𝑖𝑖) · 100 
 
 
where Ac,(i) is the corrected peak area of the i-th component of the given preparation and n is the number of 
components of this preparation. Corrected peak area is the peak area normalized (divided) by the migration 
time of this peak. This way, defined purity degree is only an approximate measure of analyte purity given that 
molar absorption coefficients of the individual components may differ. Nevertheless, with respect to the 
expected structural similarity of the admixtures and main synthetic product, it is reasonable to assume similar 
values of their molar absorption coefficients and, thus, also a relatively good estimation of the purity degree of 
the main product. 
 
Analyses and purity degree determinations were performed by CZE in the acidic BGE I and alkaline BGE II and by 
MEKC in the alkaline BGE III. The PCA for each DAP derivative is summarized in Table 3. For all analytes, high 
degrees of purity were observed with PCA values in the range 95.0 to ∼100%. For comparison purposes, CE 
analyses for the DAP derivatives E1 and C3 in the electrolyte systems BGE I, BGE II, and BGE III are discussed 
further. The derivative E1 was found to be highly pure (PCA ∼ 100%) in all three BGEs (Figs. 2A–C and Table 3). 
For the DAP derivative C3, one nonidentified admixture (peak x) with lower electrophoretic mobility than that of 
the analyte C3 was found in BGE I and BGE II, and its purity was found to be 94.8% in BGE I and 94.1% in BGE II 
(Figs. 2D and 2E and Table 3). However, MEKC performed in BGE III revealed three nonidentified minor 
admixtures—x1, x2, and x3—and its purity was found to be 90.8% (Fig. 2F and Table 3). These and other 
examples show that significant differences in purity were detected, depending on the method (CZE or MEKC) 
and BGE used. CZE analyses on analyte C1 in BGEs I and II suggest high purity (PCA ∼ 100%), but MEKC in BGE III 
revealed two minor admixtures x1 and x2 and purity of 94.5% (see Figs. SI-1A–C in supplementary material). The 
analyte C4 exhibits high purity (PCA ∼ 100%) when analyzed as a cationby CZE in acidic BGE I, but CZE in alkaline 
BGE II and MEKC in alkaline BGE III with SDS pseudostationary phase revealed one or two minor admixtures 
indicating lower purity—97.1 and 95.0%, respectively (Figs. SI-1D–F) Thus, MEKC in BGE III with SDS seems to be 
more efficient for analysis of DAP derivatives than CZE because it was able to separate admixtures, which 
remained unrevealed by CZE analyses in BGEs I and II. 
 
Table 3. Purity degree (PCA) of DAP and its mono-N-acyl-DAP derivatives estimated by CZE in BGE I and BGE II and 
by MEKC in BGE III. 
PCA (%)    
Compound BGE I BGE II BGE III  
pH 2.54 pH 8.20 pH 8.64 
DAP ∼100 ∼100 ∼100 
A1 94.5 93.6 93.7 
A2 95.8 95.4 96.1 
A3 96.6 97.1 97.0 
A4 94.3 95.0 95.8 
A5 95.6 96.5 95.6 
A6 95.2 95.4 96.2 
C1 ∼100 ∼100 94.5 
C2 96.9 98.4 93.2 
C3 94.8 94.1 90.8 
C4 ∼100 97.1 95.0 
E1 ∼100 ∼100 ∼100 
E2 94.3 91.4 95.1 
E3 94.4 93.4 95.9 
Note. For names and structures of the compounds, see Table 1. For composition of the BGEs, see Table 2. 
 
Fig.2. Analyses of DAP derivatives E1 and C3 by CZE in BGE I and BGE II and by MEKC in BGE III: (A) E1 by CZE in 
BGE I; (B) E1 by CZE in BGE II; (C) E1 by MEKC in BGE III; (D) C3 by CZE in BGE I; (E) C3 by CZE in BGE II; (F) C3 by 
MEKC in BGE III. Sample injection: hydrodynamic, 10 mbar × 5 s, x, x1, x2, x3, nonidentified admixtures. For DAP 
derivative names and structures, see Table 1. The BGE composition and other experimental conditions are given 
in Table 2 and in “Materials and Methods”. 
 
Characterization of DAP derivatives 
DAP derivatives were also characterized by their effective electrophoretic mobilities in eight BGEs. The 
effective electrophoretic mobility at the temperature inside the capillary, meff,T, was determined from the CZE 
and MEKC experimental data using the Eq. (2): 
 
(2) 𝑚𝑚eff,𝑇𝑇 = � 1𝑡𝑡mig − 1𝑡𝑡eof� · 𝐿𝐿eff·𝐿𝐿tot𝑈𝑈sep  
 
where tmig is the migration time of the given analyte (s), teof is the migration time of the electroosmotic 
flow marker (s), Leff and Ltot are the effective and total capillary lengths (m), respectively, and Usep is the applied 
separation voltage (V). CZE and MEKC experiments were performed at different ambient temperatures (22–
26 °C) and variable input power (Joule heat). To compare the observed mobilities, the actual mobility at 
temperature T inside the capillary was recalculated to a reference mobility at 25 °C, meff,25, using Eq. (3): 
 
(3) 𝑚𝑚eff,25 = 𝑚𝑚eff,𝑇𝑇[1 − 0.020(𝑇𝑇 − 25)] 
 
The actual temperature inside the capillary for each BGE was obtained based on the experimentally measured 
dependence of temperature increase inside the capillary on the input power (Joule heat) per unit capillary 
length as described previously [37]. 
 
The values for effective electrophoretic mobilities of DAP derivatives in eight BGEs at 25 °C are presented 
in Table 4. These data exhibit a strong dependence of mobilities of DAP derivatives on pH and reflect the 
presence of the particular ionogenic groups and the ratio of effective charge versus size (Mr) of these 
compounds. Cationic effective electrophoretic mobilities determined by CZE in the acidic BGE I (0.5 M AcOH, pH 
2.54) were relatively low at approximately 5.0 MU (MU = mobility unit = 1 × 10–9 m2 V–1 s–1) due to compensation 
of the positive charge of the amino group of DAP derivatives by the partially negative charges of their two or 
three carboxyl groups. Interestingly, in the C4 DAP derivative, four fluorine atoms in the side chain significantly 
increased the acidity of the corresponding carboxyl group, resulting in a prevailing anionic form of this 
compound with negative effective mobility even in the acidic BGE I (pH 2.54). In CZE analyses in alkaline BGE II 
(100 mM Tris and 50 mM acetic acid, pH 8.20), all analyzed DAP derivatives migrated as anions. The 
derivatives A1 to A6 and E1 to E3 exhibited similar moderate negative effective mobilities in the range –13.6 to –
15.7 MU due to similar ratios of their effective charges and molecular masses. The 
derivatives C1 to C4 containing the N-acyl substituent with additional free carboxyl groups possessed an 
increased negative charge and exhibited enhanced anionic mobilities in the range –23.3 to –25.2 MU for 
compounds C1 to C3 and up to –30.4 MU for the most strongly negatively charged derivative C4. 
 
Table 4. Effective electrophoretic mobilities at 25 °C of DAP derivatives determined by CZE in BGEs I, II, IV, and V 
and by MEKC in BGEs III, VI, VII, and VIII.  
meff,25 × 109 (m2 V–1 s–
1) 
       
DAP 
derivative 
BGE I BGE II BGE III BGE IV BGE V BGE VI BGE VII BGE 
VIII  
pH 2.54 pH 
8.20 
pH 
8.64 
pH 
2.28 
pH 
2.18 
pH 
2.54 
pH 
8.20 
pH 8.20 
A1 4.7 −15.7 −14.2 7.3 8.5a −9.2a −14.2 −13.0      
8.3a −9.1a 
  
A2 5.0 −14.8 −13.6 7.0 7.8a −16.6a −11.9 −10.8      
7.7a −16.5a 
  
A3 4.8 −14.6 −13.2 7.0 7.9 −17.8a −11.8 −10.0       
−17.6a 
  
A4 5.0 −14.5 −12.7 6.9 7.9 −21.7 −9.3 −6.8      
7.8 
   
A5 4.7 −13.9 −12.2 6.7 7.6 −23.1a −8.7 −6.1       
−23.0a 
  
A6 4.4 −13.9 −11.4 6.6 8.1 −25.7a −1.2a 4.9       
−25.6a −0.7a 
 
C1 4.1 −25.2 −23.2 6.3 7.0 −10.6 −15.3 −10.5 
C2 4.3 −24.0 −23.6 6.3 7.4 −14.0a −12.3 −7.4       
–15.9a 
  
C3 4.3 −23.3 −22.9 6.2 7.4 −20.6 −8.3 ∼0 
C4 −2.4 −30.4 −29.6 ∼0 −10.3 −12.9 28.0 28,6 
E1 3.5 −14.0 −11.1 6.0 7.3 −16.0a −9.4 −7.5       
−15.8a 
  
E2 4.1 −14.3 −12.1 6.7 7.7a −19.2 −11.9 −9.4      
7.6a 
   
E3 4.9 −13.6 −11.7 6.9 7.9 −19.2a −11.5 −9.1       
−18.9a 
  
Note. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental 
conditions are given in Table 2 and in Materials and Methods. 
aEffective mobility of resolved diastereomer of DAP derivative. 
 
Similar electromigration behavior was observed in the MEKC analyses of DAP derivatives in BGE III (20 mM Tris, 
5 mM H3PO4, and 50 mM SDS, pH 8.64), where derivatives A1 to A6 and E1 to E3exhibited anionic mobilities in 
the range –11.1 to –14.2 MU and the mobilities of the compounds C1to C4 achieved values of –22.9 to –
29.6 MU. The small observed difference between mobilities in the micelle-free BGE II and those in the micelle-
containing BGE III suggests that the DAP derivatives do not strongly interact with the SDS micellar pseudophase 
of BGE III. 
 
In the CZE analyses of DAP derivatives in the isoelectric BGE IV (200 mM IDA, pH 2.28) and in the classical BGE V 
(100 mM H3PO4 and 50 mM Tris, pH 2.18), similar structure–mobility relationships of these compounds were 
observed as in the BGE I. Slightly higher cationic mobilities were observed in BGEs IV and V (∼6.0–8.0 MU) than 
in BGE I (4.0–5.0 MU), which is due to the increased positive charge of the DAP derivatives at lower pH in BGEs 
IV and V (pH 2.28 and 2.18) than in BGE I (pH 2.54). The exception to this behavior is compound C4, which 
exhibited negative mobility even under strongly acidic conditions in BGEs IV and V. 
 
An interaction between the positively charged DAP derivatives and the negatively charged SDS micellesin acidic 
BGE VI (0.5 M AcOH, pH 2.54) resulted in a negatively charged analyte–micelle complex with variable negative 
mobilities in the range –9.1 to –25.7 MU for compounds A1 to A6 and E1 to E3 and in the range –10.6 to –
20.6 MU for compounds C1 to C4. In this case, the differences in mobilities did not result from differences in the 
charge/size ratio but rather resulted from differences in the hydrophobicities of the analytes and from the 
binding strength of their complexes with SDS micelles. 
 
Negative effective charge and negative mobility were observed for nearly all DAP derivatives (with the exception 
of A6 and C4) in alkaline media such as BGE VII (100 mM Tris, 50 mM AcOH, and 5 mM CTAB, pH 8.2) and BGE 
VIII (100 mM Tris, 50 mM AcOH, and 10 mM CTAB, pH 8.2), although diminished due to their weak interaction 
with positively charged CTAB micelles. Slightly lower absolute values of mobilities in BGE VIII as compared with 
BGE VII are apparently caused by the higher concentration of CTAB in BGE VIII (10 mM) versus BGE VII (5 mM). 
Reverse migration behavior was observed for DAP derivatives containing the aromatic group (A6) in BGE VIII and 
the acidic DAP derivative C4 in BGE VII and BGE VIII. These two derivatives form strong complexes with cationic 
CTAB micelles, resulting in a positive charge and cationic migration with a low positive mobility (4.9 MU) 
for A6 and a high positive mobility (28.0–28.6 MU) for C4. It is worth noting that in some cases 
the diastereomers of the DAP derivatives were partially or completely resolved in achiral media—by CZE in BGE 
V and by MEKC in BGE VI and BGE VII (see Fig.3, Fig.4 in the next section). Thus, these separations allowed 
determination of effective electrophoretic mobilities for both diastereomers (enantiomer pairs) of these 
compounds (see Table 4). 
 
Fig.3. MEKC separation of partial mixtures of DAP derivatives in BGE VI: (A) mixture M1 (A1–A3); (B) mixture M2 
(A4–A6); (C) mixture M3 (E1–E3); (D) mixture M4 (C1–C4). Sample injection: 10 mbar × 5 s, x, nonidentified 
admixtures. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental 
conditions are given in Table 2 and in “Materials and Methods”. 
 
Fig.4. MEKC separation of the 11 DAP derivatives in BGE VI. Sample injection: 10 mbar × 5 s, x, nonidentified 
admixtures. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental 
conditions are given in Table 2 and in “Materials and Methods”. 
 
Separation of DAP derivatives 
From the eight BGEs tested, the largest differences in electrophoretic mobilities for DAP derivatives were found 
in BGE VI (0.5 M AcOH [pH 2.54] and 60 mM SDS). Consequently, the separation of mixtures of DAP derivatives 
was carried out by MEKC in this BGE. First, four partial mixtures of the analytes were constituted according to 
similarity of their N-acyl substituent (Table 1). The mixture M1 was constituted from compounds A1 to A3 with 
linear and branched C2 and C4 aliphatic acyl groups; mixture M2 from compounds A4 and A5 with linear and 
branched C5 aliphatic acyl groups, respectively, and compound A6 with an aromatic acyl group; mixture M3 
from compounds E1 to E3containing esterified carboxyl groups; and mixture M4 composed of 
compounds C1 to C4, which contain free carboxylic groups. Fig. 3 shows complete MEKC separations for all 
components of mixtures M1, M2, and M4, including a complete or partial separation of the diastereomers 
of A1, A2, A3, A5, A6, C1, and C2, whereas in mixture M3 a baseline separation of the diastereomers of E1 was 
achieved but E2 and E3 and their diastereomers comigrated. The addition of organic modifiers (methanol or 
acetonitrile) to the BGE did not improve the separation of these two compounds and their diastereomers. 
Finally, using this optimized BGE, a mixture of all DAP derivatives, with the exception of comigrating 
derivatives E2 and E3, was separated by MEKC within a short time of 11 min (Fig. 4). 
Enzyme inhibition 
All DAP derivatives were examined for their ability to inhibit the catalytic activity of HiDapE enzyme. Of the 13 
compounds tested, only A1 showed a weak inhibition of the catalytic activity with an IC50value of 17 mM. These 
data suggest that the amino moiety of mono-N-succinyl-DAP forms an important interaction within the active 
site of DapE given that the acylated amino acids did not inhibit enzymatic activity. Alternatively, the acylated 
versions of these amino acids may introduce a repulsive steric interaction because of bulky alkyl groups, thereby 
preventing enzyme binding. All of the DAP derivatives were also examined for their ability to inhibit EcArgE. 
Some of the DAP derivatives exhibited a weak inhibition toward EcArgE; the best inhibitor was E1, with an 
IC50 value of 480 μM, thereby providing a promising lead structure for further studies on ArgE inhibitors. The 
other DapE inhibitors that showed a dose-dependent response to EcArgE were A1, C1, and C3, with IC50 values 
of 2.63, 2.11, and 1.28 mM, respectively, whereas the remaining DAP derivatives did not inhibit EcArgE. It 
implies that both DapE and ArgE active sites possess strict substrate specificity with regard to both functional 
groups and stereochemistry. 
Conclusions 
The data presented here proved that IR and NMR spectroscopies and capillary electromigration methods, CZE 
and MEKC, represent powerful tools for structural analysis, purity determination, separation, and 
physicochemical characterization of amino acids and their derivatives. Structural features of mono-N-acyl 
derivatives of 2,6-DAP were characterized by IR and NMR spectroscopies, whereas purity degree and 
effective electrophoretic mobilities of cationic and anionic forms of these compounds in acidic and alkaline 
classical or isoelectric BGEs with and without anionic (SDS) or cationic (CTAB) detergents were determined by 
CZE and MEKC methods. The best separation of DAP derivatives, including diastereomers of some of them, was 
achieved by MEKC in an acidic BGE (500 mM acetic acid, pH 2.54) with micellar pseudophase constituted by 
anionic detergent, 60 mM SDS. None of the analyzed DAP derivatives worked as an effective inhibitor of catalytic 
activity of the DapE from H. influenza, but one derivative—N-fumaryl, Me-ester-DAP—was found to be a 
moderate inhibitor of ArgE from E. coli, thereby providing a promising lead structure for further studies on ArgE 
inhibitors. 
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